Table 2.
Distribution of MRI PDFF values according to different METAVIR stages of hepatic fibrosis. The Kruskal-Wallis test revealed a significant difference between groups (P < 0.05). The post-hoc analysis demonstrates that the median MRI PDFF value of the F4 subgroup is significantly lower than that of the other subgroups of patients.
| Post-hoc analysis: distribution of PDFF according to METAVIR stages of fibrosis | ||||
|---|---|---|---|---|
| Factor | n | Median (range) | Average rank | Pairwise comparisons with a significant result (P < 0.05) |
| F0 | 23 | 6.7 (0.72–17.01) | 44.61 | F0 versus F4 |
| F1 | 14 | 6.7 (0.7–15.54) | 43.25 | F1 versus F4 |
| F2 | 12 | 6.07 (3.68–15.04) | 40.33 | F2 versus F4 |
| F3 | 18 | 5.78 (3.7–15.54) | 39.36 | F3 versus F4 |
| F4 | 10 | 3.43 (1.72–5.95) | 17.90 | F4 versus F0/F1/F2/F3 |